Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
Dexcom CGMs Clinch Victories in Type 2 Diabetes and Pregnancy at EASD Conference
In the realm of continuous glucose monitors (CGMs), recent discussions have revolved around broadening their application beyond the traditional user ...
Pfizer’s Hospira Initiates Recall of 3 Drug Lots Due to Particulate Concerns
Hospira, a subsidiary of Pfizer, has taken the proactive step of issuing a voluntary recall for specific injectable medications, namely ...
FDA Identifies ‘Systemic Bias’ in Amgen’s Late-Stage Lumakras Trial Ahead of Adcomm
As an FDA advisory committee prepares to deliberate on the data supporting Amgen’s groundbreaking drug Lumakras, a pre-meeting briefing document ...
Hologic Partners with Nonprofit for ‘Know Your Lemons’ Breast Cancer Education Drive
In observance of Breast Cancer Awareness Month, Hologic is intensifying its efforts to promote breast health. The Massachusetts-based company, known ...
Johnson & Johnson Secures Talc Victory in New Jersey Court, Erasing $223M Jury Award
Johnson & Johnson, in its latest effort to address the multitude of talc-related lawsuits it faces, suffered a setback when ...
A Massive Workforce of 75,000 Kaiser Healthcare Professionals Stage Walkout
In a historic show of unity, more than 75,000 healthcare professionals, including nurses, emergency department technicians, pharmacists, and various other ...
FDA Flags Issues in Galderma’s Botulinum Toxin Filing
While Galderma seeks to expand its range of injectable aesthetic treatments by gaining FDA approval for addressing crow’s feet and ...
AstraZeneca Settles Nexium, Prilosec Lawsuits for $425M
AstraZeneca has agreed to pay £352 million ($425 million) to settle approximately 11,000 personal injury lawsuits in New Jersey and ...
Takeda withdraw Global Lung Cancer Medication, Exkivity, Following Confirmatory Trial Failure
Following a disappointing outcome in a confirmatory trial earlier this year, Takeda has decided to discontinue its targeted non-small cell ...
Galderma Initiates Breast Cancer Campaign Focusing on Aesthetic Solutions for Survivor Confidence
In observance of Breast Cancer Awareness Month this October, Galderma, a specialist in dermatology, has partnered with the National Breast ...
ALX Oncology’s CD47 Drug Shows Enhanced Response in Solid Tumors, Aiming for Phase 3 Trials
ALX Oncology is reevaluating the potential of its anti-CD47 drug in the context of solid tumors, buoyed by promising data. ...
Sanofi Invests $175M in J&J’s Advanced E. coli Vaccine, Amplifying its Vaccine Development Efforts
Sanofi is making a strategic move by investing $175 million in Johnson & Johnson’s late-phase E. coli vaccine, ExPEC9V. As ...
FDA Approves Novo Nordisk’s Rivfloza, Setting Stage for Market Duel with Alnylam
Novo Nordisk, known for its popular obesity therapy Wegovy, has achieved a significant milestone with the FDA approval of Rivfloza, ...
Amicus Seals $430M Financing from Blackstone Post-Pompe Disease Drug Approval
Fresh from securing FDA approval for its combination treatment targeting Pompe disease, Amicus Therapeutics has attracted a significant investment. Amicus ...
Viatris Divests in Major Restructure, Letting Go of 3 Units, 6,000 Staff, and 10 Plants
As Viatris charts its course to reposition itself as a focused eye care enterprise, the company is streamlining its operations ...
ICER Reviews BMS’ Eliquis, J&J’s Xarelto Amidst Medicare Price Talks
As the United States embarks on a new era of drug price negotiations, the Institute for Clinical and Economic Review ...
Infinity Declares Bankruptcy, Signaling an Unexpected End to Its Operations
Following an unsuccessful merger attempt with MEI Pharma, Infinity Pharma has made the difficult decision to file for bankruptcy, a ...
Zeiss and Boehringer Ingelheim Collaborate on AI Initiative to Detect and Address Eye Diseases Earlier
A groundbreaking collaboration between Zeiss Medical Technology and Boehringer Ingelheim is set to revolutionise the early detection and treatment of ...
Novo Nordisk Opposes, Then Joins CMS Drug Pricing Program Amidst Industry Tensions
Novo Nordisk has become the latest player in the biopharmaceutical industry to challenge the drug price negotiation provisions outlined in ...
Eli Lilly Faces Third FDA Rejection in 2023, Eczema Drug Lebrikizumab Denied Approval
Eli Lilly, which had set ambitious plans to introduce four new drugs in 2023, has faced another setback on the ...
FDA Approves Biogen’s Biosimilar, Challenging Roche’s Actemra Dominance in the Market
Biogen has achieved a remarkable milestone while contemplating the future of its biosimilars division. The company proudly announced that its ...
Johnson & Johnson Offers Global Access by Not Enforcing Sirturo’s Tuberculosis Drug Secondary Patents
Johnson & Johnson has taken significant steps to improve access to its multidrug-resistant tuberculosis (MDR-TB) medication, Sirturo (bedaquiline), in low- ...
Biotech IPOs: Abivax and Lexeo debut on Nasdaq, Apnimed delays listing
AbiVax and Lexeo Therapeutics have recently made their debut in the world of initial public offerings (IPOs), marking the commencement ...
Medtronic to sell its medical supplies unit to Carlyle Group for $7 billion
In a significant development nearly a year after Medtronic’s announcement of its intention to spin off its patient monitoring and ...
Invitae gets FDA approval for blood test that detects hereditary cancer genes
Invitae has achieved a significant milestone with the FDA granting de novo clearance for its groundbreaking blood test. This test ...
Syros slashes workforce and appoints new CEO amid partnership losses
Syros Pharmaceuticals is undergoing a significant transformation, which includes a workforce reduction of 35%, as it narrows its focus to ...
Novartis’ iptacopan impresses in phase 3 trial for rare kidney disease
Novartis is celebrating a significant achievement as its investigational oral factor B inhibitor reaches a crucial milestone in a phase ...
J&J teams up with renowned photographer and author to promote eye health awareness
Johnson & Johnson is embarking on a transformative vision campaign, joining forces with renowned New York Times best-selling author, Kate ...
Syndax Halts Pivotal Cancer Trial Prematurely Due to Efficacy, Stock Dips Amid Disappointing Details
Syndax Pharmaceuticals, based in Massachusetts, has made a significant decision to prematurely conclude a pivotal cancer clinical trial, leading to ...
Estée Lauder’s Pink Ribbon Campaign for Breast Cancer
With a historic legacy of three decades of unwavering dedication to breast cancer awareness, the Estée Lauder Companies are set ...
